[1]
Altankhuyag, A. et al. 2022. The Efficacy of Intravitreal Bevacizumab in Neovascular Age-Related Macular Degeneration. Central Asian Journal of Medical Sciences. 8, 4 (Dec. 2022), 251–257. DOI:https://doi.org/10.24079/cajms.2022.12.007.